Skip to main content
. Author manuscript; available in PMC: 2012 Sep 15.
Published in final edited form as: Clin Cancer Res. 2011 Aug 3;17(18):5945–5952. doi: 10.1158/1078-0432.CCR-11-0970

Figure 2.

Figure 2

The cytotoxic function of VL peptide-specific CTLs against Id peptide or control HIV peptide pulsed T2 cells. (A)The cytotoxic function of U266 derived VL peptide-specific CTLs was tested against T2 cells pulsed with U266 or control HIV peptide. (B) The cytotoxic function of donor CTL raised against primary B-cell tumor-derived VL peptides was tested against T2 cells pulsed with the respective human tumor-derived or control HIV peptide. Results are representative of three independent experiments.